387570.Kq
The company operates in the healthcare services and equipment industry, primarily generating revenue through the provision of medical equipment, supplies, and distribution services.
Business. The company operates in the healthcare services and equipment industry, primarily generating revenue through the provision of medical equipment, supplies, and distribution services.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
The company operates in the healthcare services and equipment industry, primarily generating revenue through the provision of medical equipment, supplies, and distribution services.
The company's capital structure is characterized by a relatively low debt-to-equity ratio of 0.21, indicating a conservative leverage position compared to industry norms. However, the company's liquidity position is mixed, with a current ratio of 5.3, suggesting strong short-term liquidity, but negative operating and free cash flows of -2.63 billion KRW and -1.77 billion KRW, respectively, signaling cash flow challenges. The price-to-book ratio of 1.97 implies that the market values the company at a premium to its book value, but this is not supported by positive earnings or cash flow generation.
Profitability metrics are weak, with a return on equity of -9.88% and a return on assets of -7.36%, both significantly below the industry median. The company reported a net loss of 1.88 billion KRW and an operating loss of 2.58 billion KRW, indicating a lack of operational efficiency and cost control. Gross profit of 4.6 billion KRW represents 48.3% of revenue, which is a standard margin for the industry, but the inability to convert this into operating profit highlights structural inefficiencies.
The company's revenue is not segmented by geographic region or product line in the available data, making it difficult to assess geographic or product concentration risk. However, the absence of disclosed geographic diversification suggests potential overreliance on a single market, which could expose the company to regional economic or regulatory shocks.
The company's growth trajectory is uncertain, with no specific revenue growth or decline figures provided for the current or next fiscal year. The negative operating and free cash flows suggest that the company may struggle to fund growth initiatives without external financing, which could lead to increased leverage or dilution. The company's capital expenditures of -853 million KRW indicate ongoing investment, but the negative sign suggests these are outflows rather than gains.
The company's risk profile is elevated due to its negative net cash position after subtracting total debt, which indicates a potential liquidity constraint. While the dilution risk is currently assessed as low, the company's negative cash flows and operating losses could necessitate future equity or debt financing, increasing the likelihood of dilution. The company's financial performance and cash flow issues also raise concerns about its credit risk, as it may struggle to meet debt obligations.
No recent events, such as filings or transcripts, are provided in the available data to inform the company's current strategic direction or operational changes. The absence of such information limits the ability to assess the company's response to market conditions or regulatory developments.
- The company has a conservative debt structure but is experiencing negative operating and free cash flows.
- Profitability is weak, with negative returns on equity and assets.
- The company's revenue is not segmented, making it difficult to assess geographic or product concentration risk.
- Growth is uncertain, and the company may need external financing to fund operations or expansion.
- The company's liquidity position is mixed, with a strong current ratio but negative cash flows.
Bull / Bear case
analysis pipelineIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- Net cash is negative after subtracting total debt.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Return On Equitynet_income / total_equity
- Price To Bookmarket_price / (adjusted_book_value / shares_outstanding_diluted)
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Market Priceinput from market-data provider (delayed close or quote-shim mid)
- Market Capmarket_price * shares_outstanding_diluted
- Ev To Revenueenterprise_value / revenue
- 387570.KQ Market data — financials · 2026-05-26